EWTX - Edgewise Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.00
DETAILS
HIGH:
$52.00
LOW:
$25.00
MEDIAN:
$45.50
CONSENSUS:
$42.00
UPSIDE:
28.44%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 2.3 | 0 | 0 | 0 | 0 | 0.2 | 0.1 |
| Gross Profit | (2.3) | 0 | 0 | 0 | 0 | (0.2) | (0.1) |
| Operating Expenses | |||||||
| R&D Expenses | 151.4 | 127.0 | 90.9 | 54.0 | 32.2 | 14.8 | 8.6 |
| SG&A Expenses | 40.0 | 31.9 | 23.5 | 17.6 | 11.0 | 2.2 | 1.3 |
| Other Expenses | (2.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 189.1 | 158.8 | 114.4 | 71.7 | 43.2 | 17.0 | 9.9 |
| Operating Income | |||||||
| Operating Income | (191.4) | (158.8) | (114.4) | (71.7) | (43.2) | (17.2) | (9.9) |
| Interest Expense | 0 | 0 | 0 | 4.0 | 0 | 0 | 0 |
| Interest Income | 23.6 | 25.0 | 14.2 | 2.7 | 0.4 | 0.1 | 0.2 |
| Profitability | |||||||
| EBITDA | (165.5) | (156.5) | (112.6) | (71.1) | (42.9) | (17.0) | (9.8) |
| EBIT | (167.8) | (158.8) | (114.4) | (71.7) | (43.2) | (17.2) | (9.9) |
| Income Before Tax | (167.8) | (133.8) | (100.2) | (67.6) | (42.8) | (17.1) | (9.7) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (167.8) | (133.8) | (100.2) | (67.6) | (42.8) | (17.1) | (9.5) |
| Per Share Data | |||||||
| EPS (Basic) | -1.63 | -1.45 | -1.57 | -1.26 | -0.86 | -0.35 | -0.19 |
| EPS (Diluted) | -1.63 | -1.45 | -1.57 | -1.26 | -0.86 | -0.35 | -0.19 |
| Shares Outstanding | 102.9 | 92.4 | 63.7 | 53.6 | 49.5 | 49.2 | 49.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 61.1 | 41.7 | 86.1 | 22.0 | 15.6 | 104.9 | 23.7 |
| Short-Term Investments | 469.0 | 428.5 | 232.3 | 330.0 | 265.2 | 24.2 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 13.3 | 5.3 | 8.6 | 0 | 0 | 0 | 0 |
| Total Current Assets | 543.4 | 475.5 | 327.0 | 357.0 | 283.8 | 129.6 | 24.0 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 9.2 | 11.1 | 12.7 | 9.9 | 0.9 | 0.5 | 0.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0.3 | 0.3 | 0.3 | 0.5 | 1.0 | 0 |
| Total Non-Current Assets | 9.2 | 11.3 | 13.0 | 10.1 | 1.5 | 1.5 | 0.5 |
| Total Assets | 552.6 | 486.8 | 340.0 | 367.1 | 285.2 | 131.1 | 24.5 |
| Current Liabilities | |||||||
| Account Payables | 6.0 | 5.6 | 4.0 | 6.1 | 3.8 | 1.6 | 0.7 |
| Short-Term Debt | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 20.4 | 10.1 | 5.7 | 4.0 | 2.8 | 0.5 | 0.3 |
| Total Current Liabilities | 27.4 | 23.9 | 16.8 | 16.6 | 10.5 | 4.3 | 1.1 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 3.0 | 0 | 0 | 0 | 0 | 160.2 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0.3 | 0 | 40.3 |
| Total Non-Current Liabilities | 3.0 | 3.7 | 4.4 | 3.8 | 0.3 | 160.2 | 40.3 |
| Total Liabilities | 30.3 | 27.6 | 21.2 | 20.4 | 10.8 | 164.6 | 41.4 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (546.4) | (378.6) | (244.8) | (144.6) | (77.0) | (34.1) | (17.0) |
| Accumulated Other Comprehensive Income | 0.7 | 0.4 | 0.1 | (1.4) | (0.5) | 0 | 0 |
| Total Stockholders' Equity | 522.3 | 459.2 | 318.8 | 346.7 | 274.4 | (33.4) | (16.9) |
| Total Liabilities & Equity | 552.6 | 486.8 | 340.0 | 367.1 | 285.2 | 131.1 | 24.5 |
| Debt Metrics | |||||||
| Total Debt | 4.0 | 4.7 | 5.4 | 4.4 | 0 | 160.2 | 0 |
| Net Debt | (57.2) | (36.9) | (80.7) | (17.6) | (15.6) | 55.3 | (23.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (167.8) | (133.8) | (100.2) | (67.6) | (42.8) | (17.1) | (9.7) |
| Depreciation & Amortization | 2.3 | 2.3 | 1.7 | 0.5 | 0.3 | 0.2 | 0.1 |
| Stock-Based Compensation | 0 | 24.7 | 17.6 | 10.9 | 4.4 | 0.4 | 0.1 |
| Change in Working Capital | (5.4) | 10.3 | (1.6) | 4.1 | 4.6 | 1.9 | 0.3 |
| Other Non-Cash Items | 27.1 | (12.5) | (9.5) | (0.5) | 2.3 | 0 | 0 |
| Operating Cash Flow | (143.8) | (109.0) | (91.9) | (52.6) | (33.5) | (14.6) | (9.2) |
| Investing Activities | |||||||
| Capital Expenditure | (0.3) | (1.3) | (5.7) | (5.5) | (0.7) | (0.2) | (0.2) |
| Acquisitions | 0 | 0 | 0 | 0.1 | 0.2 | 0 | 0 |
| Purchases of Investments | (527.2) | (477.1) | (255.9) | (292.4) | (288.2) | (24.2) | 0 |
| Sales/Maturities of Investments | 494.7 | 293.7 | 364.5 | 227.4 | 46.6 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (0.1) | (0.2) | 0 | 0 |
| Investing Cash Flow | (32.8) | (184.7) | 102.9 | (70.6) | (242.2) | (24.4) | (0.2) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 10.1 | 0.5 | 0.5 | 0.2 | 0.2 | 0.0 |
| Financing Cash Flow | 196.1 | 249.3 | 53.2 | 129.6 | 186.4 | 120.3 | 24.8 |
| Cash Position | |||||||
| Net Change in Cash | 19.5 | (44.4) | 64.1 | 6.4 | (89.3) | 81.3 | 15.4 |
| Cash at Beginning | 41.7 | 86.1 | 22.0 | 15.6 | 104.9 | 23.7 | 8.2 |
| Cash at End | 61.1 | 41.7 | 86.1 | 22.0 | 15.6 | 104.9 | 23.7 |
| Free Cash Flow | (143.8) | (110.3) | (97.7) | (58.2) | (34.2) | (14.8) | (9.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (2.3) | 0 | 0 | 0 | 0 | (0.2) | (0.1) |
| Operating Income | (191.4) | (158.8) | (114.4) | (71.7) | (43.2) | (17.2) | (9.9) |
| Net Income | (167.8) | (133.8) | (100.2) | (67.6) | (42.8) | (17.1) | (9.5) |
| EPS (Diluted) | -1.63 | -1.45 | -1.57 | -1.26 | -0.86 | -0.35 | -0.19 |
| Balance Sheet | |||||||
| Cash & Equivalents | 61.1 | 41.7 | 86.1 | 22.0 | 15.6 | 104.9 | 23.7 |
| Total Assets | 552.6 | 486.8 | 340.0 | 367.1 | 285.2 | 131.1 | 24.5 |
| Total Debt | 4.0 | 4.7 | 5.4 | 4.4 | 0 | 160.2 | 0 |
| Stockholders' Equity | 522.3 | 459.2 | 318.8 | 346.7 | 274.4 | (33.4) | (16.9) |
| Cash Flow | |||||||
| Operating Cash Flow | (143.8) | (109.0) | (91.9) | (52.6) | (33.5) | (14.6) | (9.2) |
| Capital Expenditure | (0.3) | (1.3) | (5.7) | (5.5) | (0.7) | (0.2) | (0.2) |
| Free Cash Flow | (143.8) | (110.3) | (97.7) | (58.2) | (34.2) | (14.8) | (9.4) |